Capítulo I – Revisão de Literatura
4
61. Steers WD. Physiology and pharmacology of the bladder and urethra. In:
Walsh PC, Retnik AB, Vaughan Jr ED, Wein AJ, editors. Campbell’s
Urology. 7
th
ed. Philadelphia: W.B. Saunders Co.; 1998. p. 870-915.
62. Stasi SM, Giannantoni A, Navarra P, Capelli G, Storti L, Porena M, et al.
Intravesical oxybutynin: mode of action assessed by passive diffusion and
electromotive administration with pharmacokinetics of oxybutynin and n-
desethyl oxybutynin. J Urol. 2001; 166: 2232-6.
63. Gupta SK, Sathyan G, Lindemulder EA, Ho PL, Sheiner LB, Aarons L.
Quantitative characterization of therapeutic index: application of mixed-
effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect
relationships. Clin Pharmacol Ther. 1999; 65: 672-84.
64. Birns J, Luccari E, Malone-Lee JG. A randomized controlled trial
comparing the efficacy of controlled-release oxybutynin tablets (10 mg once
daily) with conventional oxybutynin tablets (5 mg twice daily) in patients
whose symptoms were stabilized on 5 mg twice daily of oxybutynin. BJU
Int. 2000; 85: 793-8.
65. Mulcahy JJ, James HE, Mc Roberts JW. Oxybutynin chloride combined
with intermittent clean catheterization in the treatment of
myelomeningocele patients. J Urol. 1977; 118: 95-6.
66. Bauer SB. Neurogenic dysfunction of the lower urinary tract in children. In:
Walsh PC, Retnik AB, Vaughan Jr ED, Wein AJ, editors. Campbell’s
Urology. 7
th
ed. Philadelphia: W.B. Saunders Co.; 1998. p.2019-53.
67. Lapides J, Diokono AC, Silber SJ. Clean intermittent self-catheterization in
the treatment of urinary tract disease. J Urol. 1972; 107: 458-61.
68. Optiz JL, Thorsteinsson G, Schutt AH, Barret DM, Olson PK. Bexiga e
intestino neurogênicos. Reabilitação: princípios e práticas. São Paulo:
Manole; 1992. p. 571-81.
69. Kaplinsk R, Greenfield S, Wan J, Fera M. Expanded follow up of
intravesical oxybutynin chloride use in children with neurogenic bladder. J
Urol. 1996; 156: 753-6.
70. Brendler CB, Radebaugh LC, Mohler JL. Topical oxybutynin chloride for
relaxation of dysfunctional bladders. J Urol. 1989; 141: 1350-2.